Unverified listing. No listed contact route; a strong testing record with no assessable operation behind it. It is left out of our vendor rankings; its published test results still appear on compound leaderboards, marked Unverified. Vendors can change this by publishing verifiable results and a storefront we can assess.

Yimei

Score computed from 117 publicly published third-party lab results. Every input links to its source below.

If you buy through our link or code we may earn a commission. This never affects scores or rank position.

PEPTIDECENSUS SCORE
73
of 100 · 117 verified results
How scoring works

Is Yimei legit?

Yimei is an unverified PeptideCensus listing. No listed contact route; a strong testing record with no assessable operation behind it. Its 117 published third-party results still appear on our compound boards, marked Unverified.

The Finnrick directory counts 117 published third-party results for Yimei, the latest dated 21 Aug 2026. It appears on 13 compound boards; its best scored placement is #1 on the hCG board, scoring 59 from 4 tests.

Whichever seller you use, match the certificate to the lab's own records before trusting a vial: search its code in the Freedom Diagnostics lookup or check a Janoshik report with its key (how to verify a Janoshik report). A certificate covers one tested batch, so compare its batch number and date with the vial you receive.

Where this vendor ranks

13 compound boards · refreshed daily
CompoundRankScoreTestsPrice/mgLast test
hCG #1 59 4 $0.60 25 Sept 2026
Epithalon #1 40 3 $0.48 21 Aug 2026
GHK-Cu #2 94 17 $0.10 21 Aug 2026
Ipamorelin #2 83 8 $1.14 30 Apr 2026
CJC-1295 #2 47 7 $2.58 30 Apr 2026
TB-500 #3 47 7 $2.00 21 Aug 2026
NAD+ #3 29 4 $0.02 25 Sept 2026
MOTS-c #4 38 3 $0.71 6 May 2026
Tesamorelin #9 57 6 $3.69 7 Mar 2026
Melanotan I #10 — — $0.76 —
BPC-157 #15 58 12 $1.00 21 Aug 2026
DSIP #17 — — $3.60 —
GLOW #22 — — $0.44 —

Every leaderboard placement we track; each row links to the full board and its source record. Rows without scores are rating-level listings the published testing has not yet covered.